Intrathecal colistin for treatment of highly resistant Pseudomonas ventriculitis

Journal of Neurosurgery

Volumn 102, Issue 5, 2005, Pages 915-917

  Gump, William C ^a,b   Walsh, John W ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SL47 ^*  (United States)

Author keywords

Intrathecal colistin; Shunt infection; Ventriculitis

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; COLISTIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANAMNESIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BRAIN VENTRICLE PERITONEUM SHUNT; BRAIN VENTRICULITIS; CARDIOVASCULAR SYSTEM EXAMINATION; CASE REPORT; FEMALE; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SHUNT INFECTION; BRAIN VENTRICLE; CEREBROSPINAL FLUID SHUNTING; CROSS INFECTION; ENCEPHALITIS; GRAM NEGATIVE INFECTION; INTRASPINAL DRUG ADMINISTRATION; MIDDLE AGED; MULTIDRUG RESISTANCE; POSTOPERATIVE COMPLICATION;

ANTI-BACTERIAL AGENTS; CEREBRAL VENTRICLES; CEREBROSPINAL FLUID SHUNTS; COLISTIN; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; ENCEPHALITIS; FEMALE; HUMANS; INJECTIONS, SPINAL; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PSEUDOMONAS INFECTIONS;

EID: 20144367377     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2005.102.5.0915     Document Type: Review

References (11)

1. Bratzler DW, Houck PM, the Surgical Infection Prevention Guidelines Writers Workgroup: Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38:1706-1715, 2004
2. Clifford HE, Stewart GT: Intraventricular administration of a new derivative of polymyxin B in meningitis due to Ps. pyocyanea. Lancet 2:177-180, 1961
3. Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A: Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis 28:916-917, 1999
4. Jimenez-Mejias ME, Becerril B, Marquez-Rivas FJ, Pichardo C, Cuberos L, Pachon J: Successful treatment of multidrug-resistant Acinetobacter baumanniimeningitis with intravenous colistin sulfomethate sodium. Eur J Clin Microbiol Infect Dis 19:970-971, 2000
5. Jiminez-Mejias ME, Pichardo-Guerrero C, Marquez-Rivas FJ, Martin-Lozano D, Prados T, Pachon J: Cerebrospinal fluid penetration and pharmacokinetic/ pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 21:212-214, 2002
6. Kapusnik-Uner JE, Sande MA, Chambers HF: Tetracyclines, chloramphenicol, erythromycin, and miscellaneous antimicrobial agents, in Hardman JG, Limbird LE, Molinoff PB, et al (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed 9. New York: McGraw-Hill, 1996, pp 1143-1144
7. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, et al: Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumanii. Clin Infect Dis 28:1008-1011, 1999
8. Prabhu VC, Kaufman HH, Voelker JL, Aronoff SC, Niewiadomska-Bugaj M, Mascaro S, et al: Prophylactic antibiotics with intracranial pressure monitors and external ventricular drains: a review of the evidence. Surg Neurol 52:226-237, 1999
9. Shenep JL, Barton RP, Mogan KA: Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis 151:1012-1018, 1985
10. Tauber MG, Shibl AM, Hackbarth CJ, Larrick JW, Sande MA: Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis 156:456-462, 1987
11. Vasen W, Desmery P, Ilutovich P, Di Martino A: Intrathecal use of colistin. J Clin Microbiol 38:3523, 2000 (Letter)